Liya Su
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- Protein Hydrolysis and Bioactive Peptides 4
- Epigenetics and DNA Methylation 3
- Ubiquitin and proteasome pathways 2
- Epidemiology 16
- Mycobacterium research and diagnosis 13
- Co-authors
- Sheldon T. Brown (12 shared papers)Robert J. Greenstein (13 shared papers)Guangliang Huang (4 shared papers)Ming Kuang (4 shared papers)Tongyi Huang (4 shared papers)Jieyi Ye (2 shared papers)Baoxian Liu (3 shared papers)Bowen Zhuang (2 shared papers)
- Journals
- PLoS ONE (5 papers)International Journal of Nanomedicine (3 papers)AIDS Research and Human Retroviruses (2 papers)Abdominal Radiology (2 papers)International Journal of Infectious Diseases (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Liya Su
64 papers receiving 1.5k citations
Liya Su's Hit Papers
Peers
Comparison fields: 5 of 122
- Hepatology 196
- Virology 79
- Health Informatics 20
- Transplantation 23
- Epidemiology 255
Countries citing papers authored by Liya Su
This map shows the geographic impact of Liya Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liya Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liya Su more than expected).
Fields of papers citing papers by Liya Su
This network shows the impact of papers produced by Liya Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liya Su. The network helps show where Liya Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Liya Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Supramolecular Photothermal Nanomedicine Mediated Distant Tumor Inhibition via PD-1 and TIM-3 Blockage Hit paper breakdown → | 2020 | 322 |
| 2 | 2020 | 108 | |
| 3 | 2020 | 102 | |
| 4 | 1997 | 86 | |
| 5 | 2007 | 70 | |
| 6 | 2014 | 59 | |
| 7 | 2019 | 58 | |
| 8 | 2007 | 48 | |
| 9 | 2008 | 39 | |
| 10 | 2012 | 39 | |
| 11 | Anticancer bioactive peptide suppresses human gastric cancer growth through modulation of apoptosis and the cell cycle. | 2010 | 39 |
| 12 | 2014 | 36 | |
| 13 | 2022 | 36 | |
| 14 | 2015 | 34 | |
| 15 | 2008 | 28 | |
| 16 | 2021 | 20 | |
| 17 | 1997 | 20 | |
| 18 | 2024 | 19 | |
| 19 | 2023 | 16 | |
| 20 | 1997 | 15 |
About Liya Su
Liya Su is a scholar working on Molecular Biology, Epidemiology, Hepatology, Biotechnology and Immunology, having authored 66 papers that have together received 1.5k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Protein Hydrolysis and Bioactive Peptides (4 papers), Cancer Research and Treatments (4 papers), Cancer Mechanisms and Therapy (3 papers), Epigenetics and DNA Methylation (3 papers), Reproductive Biology and Fertility (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Hepatology (196 citations), Virology (79 citations), Health Informatics (20 citations), Transplantation (23 citations) and Epidemiology (255 citations). Liya Su has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Sheldon T. Brown, Robert J. Greenstein, Guangliang Huang, Ming Kuang, Tongyi Huang, Jieyi Ye, Baoxian Liu, Bowen Zhuang, Ming Xu and Chunyang Zhang. Their work appears in journals such as PLoS ONE, International Journal of Nanomedicine, AIDS Research and Human Retroviruses, Abdominal Radiology and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.